2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round
Insulet Corp N/A
Cellective Therapeutics Inc N/A
BioRexis Pharmaceutical Corp Series B
Celula Inc N/A
Nura Inc N/A
Azevan Pharmaceuticals Inc N/A
Enteric Medical Technologies Inc N/A
Memory Pharmaceuticals Corp N/A
Regado Biosciences Inc N/A
Catena Pharmaceuticals Inc Focused on the development and commercialization of novel GPCR antagonists N/A
Alaven Pharmaceutical LLC Develop and market niche pharmaceutical products N/A
RareCyte Inc
Aptalis Pharma Inc
Kemia Inc
CardioKine Inc A specialty pharmaceutical company, engages in the development of pharmaceuticals for the treatment and prevention of cardiovascular diseases. N/A
NitroMed Inc Pharmaceutical company focused on the research, development, and commercialization of pharmaceuticals for cardiovascular and inflammatory diseases. N/A
Aspreva International Ltd Series A
Cyrenaic Pharmaceuticals Cyrenaic Pharmaceuticals is developing a compound for schizophrenia and bipolar disorder. N/A
QR Pharma Inc Develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases N/A
Neuron Systems Inc Developing novel therapeutics for the treatment of eye diseases N/A

Pages

Selected companies

Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products